BGB-283

2 stories · following the connections

Business

BeiGene Presents Phase IB Data on RAF Dimer Inhibitor BGB-283 at the 2017 American Association for Cancer Research Annual Meeting

By Nasdaq OMXApr 2, 2017, 5:16 PM UTC

Business

BeiGene Announces Presentation of Phase IB Data on BGB-283 at the 2017 American Association for Cancer Research Annual Meeting

By Nasdaq OMXMar 2, 2017, 2:01 PM UTC